Last reviewed · How we verify

NCT01805219: ActiGPS

Global Positioning Satellite and Accelerometry to Assess Human Locomotion (ACTI GPS)

Completed Last updated 6 November 2019
What this trial tests

trial testing GPS and accelerometer recording (s) during exercises in Healthy Volunteers in 67 participants. Completed in 8 June 2016.

Timeline
1 February 2013
Primary endpoint
8 June 2016
8 June 2016

Quick facts

Lead sponsorUniversity Hospital, Angers
StatusCompleted
Study typeOBSERVATIONAL
Enrollment67
Start date1 February 2013
Primary completion8 June 2016
Estimated completion8 June 2016
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Angers

Who can join

18 and older, any sex, with Healthy Volunteers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to validate the association of the GPS and accelerometer tools in order to assess the humain locomotion during exercises. The hypotheses are: 1. GPS and accelerometer together can assess the human locomotion 2. GPS and accelerometer together can assess the energy expenditure during exercises

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy Volunteers

Currently open trials in the same condition.

Other University Hospital, Angers trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01805219.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing